Berberine and Altered Fasting Glucose

Last updated: February 15, 2022
Sponsor: Azienda di Servizi alla Persona di Pavia
Overall Status: Active - Recruiting

Phase

N/A

Condition

Metabolic Disorders

Treatment

N/A

Clinical Study ID

NCT05031715
ID 0912/14122018
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of the study was to evaluate the effectiveness of a food supplement, berberine phytosome, which contributes to the control of blood sugar and the improvement of insulin resistance.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Fasting blood glucose range:100-125 mg/dl

Exclusion

Exclusion Criteria:

  • Diabetes mellitus

Study Design

Total Participants: 50
Study Start date:
March 02, 2020
Estimated Completion Date:
July 25, 2022

Connect with a study center

  • Mariangela Rondanelli

    Pavia, 27100
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.